Pentraxin 3, a sensitive early marker of hemodialysis-induced inflammation

Blood Purif. 2012;34(3-4):290-7. doi: 10.1159/000342630. Epub 2012 Dec 7.

Abstract

Background/aims: The purpose of this investigation was to determine if the long pentraxin 3 (PTX-3) may be a useful marker of intradialytic inflammation since it is rapidly released in the vasculature.

Methods: PTX-3, interleukin-6, tumor necrosis factor-α and C-reactive protein were measured before and during a hemodialysis session in 22 patients and compared with healthy subjects. The effect of dialysis with low-flux, high-flux membranes and hemodiafiltration on the inflammatory response was compared in 11 patients.

Results: C-reactive protein and interleukin-6 levels did not change, while a modest decrease in tumor necrosis factor-α was observed during hemodialysis. The plasma PTX-3 concentration was significantly increased (p < 0.001) after 60 min and peaked at 180 min during hemodialysis. There was no difference in the intradialytic increase in PTX-3 using different dialysis membranes and modalities.

Conclusion: PTX-3 stands out as a rapid and sensitive marker of hemodialysis-induced inflammation. Membrane flux and hemodiafiltration did not alter the inflammatory response.

MeSH terms

  • Adult
  • Aged
  • Biomarkers / blood
  • C-Reactive Protein / metabolism*
  • Female
  • Hemodiafiltration / adverse effects*
  • Humans
  • Inflammation / blood*
  • Inflammation / diagnosis
  • Inflammation / etiology*
  • Inflammation Mediators / blood
  • Kidney Failure, Chronic / blood*
  • Kidney Failure, Chronic / therapy*
  • Male
  • Middle Aged
  • Serum Amyloid P-Component / metabolism*
  • Time Factors

Substances

  • Biomarkers
  • Inflammation Mediators
  • Serum Amyloid P-Component
  • PTX3 protein
  • C-Reactive Protein